This group also explored the regulation of IRS1, active in type 2 diabetes and coronary artery disease, discussing the possible regulatory role of GWAS SNPs in sites 600 Kb and 1 Mb downstream from the IRS1 gene promoter. This evidence concerns the gene IRS1 and coronary artery disorder.